ATE406868T1 - Verwendung einer zusammensetzung mit vitamin k1- oxid oder einem derivat daraus zur behandlung und/oder vorbeugung von hautverletzungen bei säugern - Google Patents

Verwendung einer zusammensetzung mit vitamin k1- oxid oder einem derivat daraus zur behandlung und/oder vorbeugung von hautverletzungen bei säugern

Info

Publication number: ATE406868T1
Authority: AT; Austria
Prior art keywords: derivative; oxide; prevention; treatment; mammals
Prior art date: 2003-01-20

Application number

AT04703319T

Other languages

English (en)

Inventor

Alfred Marchal

Original Assignee

Auriga Internat S A

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-01-20

Filing date

2004-01-20

Publication date

2008-09-15

2003-01-28 Priority claimed from EP03447019A external-priority patent/EP1442738A1/de

2004-01-20 Application filed by Auriga Internat S A filed Critical Auriga Internat S A

2008-09-15 Application granted granted Critical

2008-09-15 Publication of ATE406868T1 publication Critical patent/ATE406868T1/de

Links

KUTXFBIHPWIDJQ-BTPXSFBUSA-N (1ar,7as)-7a-methyl-1a-[(e,7r,11r)-3,7,11,15-tetramethylhexadec-2-enyl]naphtho[2,3-b]oxirene-2,7-dione Chemical compound O=C1C2=CC=CC=C2C(=O)[C@@]2(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@]1(C)O2 KUTXFBIHPWIDJQ-BTPXSFBUSA-N 0.000 title abstract 3
241000124008 Mammalia Species 0.000 title abstract 2
230000002265 prevention Effects 0.000 title abstract 2
208000028990 Skin injury Diseases 0.000 title 1
150000004347 all-trans-retinol derivatives Chemical class 0.000 title 1
239000003581 cosmetic carrier Substances 0.000 abstract 2
239000002537 cosmetic Substances 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
230000003902 lesion Effects 0.000 abstract 1
150000003904 phospholipids Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B1/00—Nanostructures formed by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Nanotechnology (AREA)
Crystallography & Structural Chemistry (AREA)
Birds (AREA)
Biophysics (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Medical Informatics (AREA)
General Engineering & Computer Science (AREA)
Diabetes (AREA)
Nutrition Science (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Hematology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Toxicology (AREA)
Cosmetics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

AT04703319T 2003-01-20 2004-01-20 Verwendung einer zusammensetzung mit vitamin k1- oxid oder einem derivat daraus zur behandlung und/oder vorbeugung von hautverletzungen bei säugern ATE406868T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US31988703P	2003-01-20	2003-01-20
EP03447019A EP1442738A1 (de)	2003-01-28	2003-01-28	Dermatologische kosmetische Zusammensetzung enthaltend Vitamin K1 Oxid

Publications (1)

Publication Number	Publication Date
ATE406868T1 true ATE406868T1 (de)	2008-09-15

Family

ID=32773677

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04703319T ATE406868T1 (de)	2003-01-20	2004-01-20	Verwendung einer zusammensetzung mit vitamin k1- oxid oder einem derivat daraus zur behandlung und/oder vorbeugung von hautverletzungen bei säugern

Country Status (13)

Country	Link
US (1)	US7939568B2 (de)
EP (1)	EP1594456B1 (de)
JP (1)	JP2006515873A (de)
KR (1)	KR20050103906A (de)
CN (1)	CN100531727C (de)
AT (1)	ATE406868T1 (de)
CA (1)	CA2513324C (de)
DE (1)	DE602004016292D1 (de)
DK (1)	DK1594456T3 (de)
ES (1)	ES2314365T3 (de)
PT (1)	PT1594456E (de)
SI (1)	SI1594456T1 (de)
WO (1)	WO2004064798A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2885802A1 (fr) *	2005-05-17	2006-11-24	Oreal	Utilisation cosmetique de la vitamine k pour ameliorer la fonction barriere de la peau
US8003839B2 (en)	2006-02-03	2011-08-23	Exxonmobil Chemical Patents Inc.	Process for generating linear apha olefin comonomers
EP1987047B1 (de)	2006-02-03	2015-07-01	ExxonMobil Chemical Patents Inc.	Verfahren zur herstellung von alpha-olefin-comonomeren
AU2008322224B2 (en) *	2007-07-24	2012-05-10	Synergia Life Sciences Pvt Limited	Treatments using vitamin K analogues and derivatives
WO2015002151A1 (ja) *	2013-07-01	2015-01-08	株式会社明治	飲食品等の光安定性の向上方法
US9421297B2 (en)	2014-04-02	2016-08-23	Adhezion Biomedical, Llc	Sterilized compositions of cyanoacrylate monomers and naphthoquinone 2,3-oxides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB744376A (en)	1952-03-08	1956-02-08	Merck & Co Inc	Vitamin emulsions
US3070499A (en) *	1960-09-19	1962-12-25	Merck & Co Inc	Parenteral aqueous solutions of fat soluble vitamins
JPH05320039A (ja) *	1991-09-20	1993-12-03	Taiyo Kagaku Co Ltd	美白化粧料
DK0643775T3 (da) *	1992-05-28	2004-09-06	Ct For Molecular Biology And M	Quinonderivater til forbedring af cellebioenergi
DE69331727D1 (de)	1992-06-30	2002-04-25	Howard K Shapiro	Verwendung einer kombination bestehend aus einem aminderivat oder aminverwandten derivat der benzoesäure und einem amino-polysaccharide zur herstellung eines medikaments fuer die behandlung von entzündlichen erkrankungen
US5510391A (en) *	1993-10-22	1996-04-23	Mayapple Holdings, Llc	Method of treating blood vessel disorders of the skin using vitamin K
US5540934A (en) *	1994-06-22	1996-07-30	Touitou; Elka	Compositions for applying active substances to or through the skin
US5945409A (en) *	1995-03-10	1999-08-31	Wilson T. Crandall	Topical moisturizing composition and method
AU2804297A (en) *	1996-04-22	1997-11-12	Advanced Polymer Systems Inc.	Method of and composition for treating disorders of the skin using vitamin k
US6180136B1 (en) *	1998-11-10	2001-01-30	Idexx Laboratories, Inc.	Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use

2004
- 2004-01-20 CN CNB2004800024903A patent/CN100531727C/zh not_active Expired - Fee Related
- 2004-01-20 SI SI200430948T patent/SI1594456T1/sl unknown
- 2004-01-20 US US10/542,914 patent/US7939568B2/en not_active Expired - Lifetime
- 2004-01-20 DK DK04703319T patent/DK1594456T3/da active
- 2004-01-20 PT PT04703319T patent/PT1594456E/pt unknown
- 2004-01-20 WO PCT/BE2004/000011 patent/WO2004064798A1/en not_active Ceased
- 2004-01-20 DE DE602004016292T patent/DE602004016292D1/de not_active Expired - Lifetime
- 2004-01-20 ES ES04703319T patent/ES2314365T3/es not_active Expired - Lifetime
- 2004-01-20 AT AT04703319T patent/ATE406868T1/de active
- 2004-01-20 JP JP2006500422A patent/JP2006515873A/ja active Pending
- 2004-01-20 EP EP04703319A patent/EP1594456B1/de not_active Expired - Lifetime
- 2004-01-20 KR KR1020057013381A patent/KR20050103906A/ko not_active Withdrawn
- 2004-01-20 CA CA2513324A patent/CA2513324C/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE602004016292D1 (de)	2008-10-16
DK1594456T3 (da)	2009-01-19
EP1594456B1 (de)	2008-09-03
CN100531727C (zh)	2009-08-26
US20060154983A1 (en)	2006-07-13
ES2314365T3 (es)	2009-03-16
SI1594456T1 (sl)	2009-02-28
CA2513324C (en)	2010-09-21
CN1738594A (zh)	2006-02-22
WO2004064798A1 (en)	2004-08-05
US7939568B2 (en)	2011-05-10
PT1594456E (pt)	2008-12-16
EP1594456A1 (de)	2005-11-16
JP2006515873A (ja)	2006-06-08
KR20050103906A (ko)	2005-11-01
CA2513324A1 (en)	2004-08-05
HK1087010A1 (zh)	2006-10-06

Legal Events

Date

Code

Title

Description

2009-04-15

UEP

Publication of translation of european patent specification

Ref document number: 1594456

Country of ref document: EP

Publication	Publication Date	Title
BR0116832A (pt)	2004-02-03	Produto desodorante, método cosmético e método de fabricação de composição desodorante
EA200901555A1 (ru)	2010-04-30	Композиция местного применения по уходу за кожей и способ лечения
ATE415962T1 (de)	2008-12-15	Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
ATE365534T1 (de)	2007-07-15	Kosmetische hautpflegezusammensetzungen
ATE361084T1 (de)	2007-05-15	Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
ATE265456T1 (de)	2004-05-15	2-amino-6-anilino-purine und deren verwendung als arzneimittel
ATE468889T1 (de)	2010-06-15	Kosmetische zusammensetzung zur behandlung von alternder und/oder gestresster haut
DE60023816D1 (de)	2005-12-15	Verwendung von Lycopin in Zusammensetzungen zur Behandlung von Hautalterungs-Erscheinungen
DE60333873D1 (de)	2010-09-30	Zubereitungen die Lotusextrakte und Methyldonatoren enthalten
ATE347401T1 (de)	2006-12-15	Kosmetische verwendung einer zusammensetzung mit mindestens einem oxazolin als wirkstoff, als abnehmprodukt und/oder zur prävention und/oder behandlung von cellulite
ATE530226T1 (de)	2011-11-15	Verwendung von sinapinsäure in nicht- therapeutischen kosmetischen und/oder topischen zubereitungen
DK0832081T3 (da)	2003-05-26	Bicykliske-aromatiske forbindelser
DE60008143D1 (de)	2004-03-11	Lipoxin-a4 und deren analoge zur behandlung von trockenen augen
ATE425752T1 (de)	2009-04-15	Verwendung von pipamperon und einem sndri, snri oder ssri zur behandlung von stimmungs- oder angststírungen
DE69703820D1 (de)	2001-02-08	Diaromatische propynyl- oder dienylverbindungen
DE69918972D1 (de)	2004-09-02	Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
CY1108607T1 (el)	2014-04-09	Συνθεσεις περιλαμβανουσες ζελατινη-γλυκινη και καροτενοειδη
ATE406868T1 (de)	2008-09-15	Verwendung einer zusammensetzung mit vitamin k1- oxid oder einem derivat daraus zur behandlung und/oder vorbeugung von hautverletzungen bei säugern
DE60128009D1 (de)	2007-05-31	Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
ES2110057T3 (es)	1998-02-01	Composicion medicinal que contiene tcf-ii.
DK1236402T3 (da)	2010-05-10	Sammensætninger indeholdende sojaprodukter
ATE376417T1 (de)	2007-11-15	Zusammensetzung enthaltend l-proline zur behandlung von vitiligo& x9;& x9;
DE50302552D1 (de)	2006-04-27	Verwendung von treosulfan und derivaten davon zur behandlung der multiplen sklerose
DE60219495D1 (de)	2007-05-24	Verwendung von Interleukin-18 zur Behandlung von UV-assoziierten Hautkrankheiten
LT2002131A (en)	2003-06-25	New use of fir oil for cosmetic